According to informed sources, Medtronic (NYSE:MDT) has made an offer for sinus implant developer Intersect ENT (NASDAQ:XENT).
The Menlo Park, CA-based device maker has struggled during the COVID-19 pandemic. Q1 sales were down 26% leading to a ~30% cut in headcount.
XENT up 35% premarket on modest volume.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.